Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

ENTRESTO SPRINKLE

SACUBITRIL; VALSARTAN

Standard Dose
15MG;16MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ENTRESTO SPRINKLE is listed in Drugs@FDA under application 218591 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SACUBITRIL; VALSARTAN Form and strength CAPSULE, PELLETS;ORAL - 15MG;16MG Sponsor NOVARTIS Submission history Latest submission status date: 2024-04-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview ENTRESTO SPRINKLE is listed in Drugs@FDA under application 218591 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SACUBITRIL; VALSARTAN Form and strength CAPSULE, PELLETS;ORAL - 15MG;16MG Sponsor NOVARTIS Submission history Latest submission status date: 2024-04-12 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
ENTRESTO SPRINKLE (SACUBITRIL; VALSARTAN) | Drug Monograph | MedicHelpline